Table 4 Control group medication of included trials for treating NASH
Control group medication | Trials number |
|---|---|
Only chemical medicine | 89 |
Polyene phosphatidylcholine capsules | 41 |
Silybin meglumine tablets/granules | 14 |
Tiopronin tablets | 6 |
Ursodeoxycholic acid tablets | 4 |
Vitamin E capsule | 3 |
Diammonium glycyrrhizinate enteric-coated capsules | 2 |
Reduced glutathione tablets/injection | 3 |
Others | 4 |
Multi-chemical medicine combination | 12 |
Chinese patent medicine | 6 |
Danning tablets | 2 |
Hugan tablets | 3 |
Yiganning tablets | 1 |
Biological products | 3 |
Bifidobacterium triptans capsules | 1 |
Bacillus licheniformis capsules | 1 |
Bacillus subtilis duplex enteric capsules | 1 |
Chinese patent medicine combined with chemical medicine | 2 |
Dangfei yiganning capsules + ursodeoxycholic acid tablets | 1 |
Silibinin tablets + polyene phosphatidylcholine capsules | 1 |
Liver protection or enzyme reduction | 1 |
Placebo | 7 |
Non-pharmacological therapy (diet/exercise) | 3 |
Self-comparison in before and after | 1 |